Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Emanuel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|June 1, 1991
Uses of immunotherapy for control of human cytomegalovirus-associated diseasesD J Emanuel
Journal of the American Chemical Society|March 2, 1977
Synthetic design, stereochemistry, and enzymatic activity of a reversed aminoacyl nucleoside: an analogue of puromycinV Nair, D J Emanuel
The Journal of Tropical Medicine and Hygiene|February 1, 1975
A survey into the the clinical presentation of Hodgkin's disease at Harare Hospital, Salisbury, RhodesiaD J Emanuel, M Gelfand
Leukemia & Lymphoma|March 1, 1997
Post-transplant EBV induced lymphoproliferative disordersK G Lucas, K E Pollok, D J Emanuel
Blood|December 29, 1998
Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative diseaseK G Lucas, F Filo, D K Heilman, et al.
Cellular Immunology|August 17, 1999
CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord bloodQ Sun, R L Burton, K E Pollok, et al.
American Journal of Obstetrics and Gynecology|March 1, 1990
Fetal cytomegalovirus infection: a case reportR L Meisel, M Alvarez, L Lynch, et al.
Blood|November 11, 1999
Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65Q Sun, K E Pollok, R L Burton, et al.
Blood|June 20, 1998
Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantationK G Lucas, R L Burton, S E Zimmerman, et al.
Transplantation|June 15, 1997
Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytesD J Emanuel, K G Lucas, G B Mallory, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|June 1, 1991
Uses of immunotherapy for control of human cytomegalovirus-associated diseasesD J Emanuel
Journal of the American Chemical Society|March 2, 1977
Synthetic design, stereochemistry, and enzymatic activity of a reversed aminoacyl nucleoside: an analogue of puromycinV Nair, D J Emanuel
The Journal of Tropical Medicine and Hygiene|February 1, 1975
A survey into the the clinical presentation of Hodgkin's disease at Harare Hospital, Salisbury, RhodesiaD J Emanuel, M Gelfand
Leukemia & Lymphoma|March 1, 1997
Post-transplant EBV induced lymphoproliferative disordersK G Lucas, K E Pollok, D J Emanuel
Blood|December 29, 1998
Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative diseaseK G Lucas, F Filo, D K Heilman, et al.
Cellular Immunology|August 17, 1999
CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord bloodQ Sun, R L Burton, K E Pollok, et al.
American Journal of Obstetrics and Gynecology|March 1, 1990
Fetal cytomegalovirus infection: a case reportR L Meisel, M Alvarez, L Lynch, et al.
Blood|November 11, 1999
Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65Q Sun, K E Pollok, R L Burton, et al.
Blood|June 20, 1998
Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantationK G Lucas, R L Burton, S E Zimmerman, et al.
Transplantation|June 15, 1997
Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytesD J Emanuel, K G Lucas, G B Mallory, et al.
Pageof 1